Earnings Insights · MCHP · Q2 FY2027

Microchip Q2 FY2027 Earnings: Growth Accelerates, but Supply Constraints Limit Near-Term Upside

By AlgovestIQ ResearchPublished

Share

Read Microchip Technology Incorporated’s results announcement (Form 8-K, filed Nov 5, 2026)

Key earnings findings

Microchip Technology (MCHP) Q2 FY2027 · results discussed on the earnings call · Form 8-K filed

  1. Microchip Technology reported Q2 FY2027 revenue of $1.62B against the $1.61B analyst estimate, a 0.8% beat, and EPS of $0.97 against the $0.94 analyst estimate, a 3.6% beat.
  2. At the midpoint, revenue guidance implies a 1% sequential decline and approximately 35.4% year-over-year growth.
  3. MCHP closed at $58.35 on Nov 6, 2026, down 10.0% from $64.85 on Nov 5, 2026, the last close before the results were released.

Sources: Microchip Technology Incorporated results announcement (SEC), the Q2 FY2027 earnings call, and AlgovestIQ reported-results and market data. All references

Did Microchip Technology beat earnings expectations?

Actual
Estimate
Surprise
Revenue
$1.62B
$1.61B
+0.8%
EPS
$0.97
$0.94
+3.6%
  • EPS has beaten the estimate in 7 of the most recent reported quarters.
  • Revenue surprise across the last 8 reported quarters has ranged from -1.9% to 3.8%.

Reported figures against analyst estimates, compiled from AlgovestIQ data.

Microchip Technology reported fiscal second-quarter revenue of $1.622B, up 42.2% year over year and 9.2% sequentially, exceeding the high end of its outlook. GAAP diluted EPS was $0.68 and non-GAAP EPS was $0.97, also above guidance. The underlying demand picture improved across industrial, aerospace and defense, automotive, and data center applications, but supply constraints in foundry, assembly, and test capacity are delaying shipments of some higher-margin products.

The December-quarter outlook implies a modest sequential decline, but management argues the comparison is distorted by $53M of infrequent, 100%-margin revenue recognized in the September quarter. The more consequential issue for investors is whether Microchip can convert its growing backlog into revenue as external manufacturing constraints ease, while preserving gross margins near its 65% long-term target.

Earnings Snapshot

MetricReportedChange
Net sales$1.622BUp 42.2% YoY; up 9.2% sequentially
GAAP gross margin65.9%Up from 55.9% YoY
Non-GAAP gross margin66.5%Up from 56.7% YoY
GAAP operating income$464.5MUp from $88.9M YoY
GAAP operating margin28.6%Up from 7.8% YoY
Non-GAAP operating income$639.9MUp from $277.2M YoY
Non-GAAP operating margin39.5%Up from 24.3% YoY
GAAP net income attributable to common stockholders$373.6MUp from $13.9M YoY
GAAP diluted EPS$0.68Up from $0.03 YoY
Non-GAAP net income$559.2MUp from $199.1M YoY
Non-GAAP diluted EPS$0.97Up from $0.35 YoY
Cash flow from operations$419.2MUp from $88.1M YoY
Free cash flow$396.1MUp from $51.6M YoY
Cash and short-term investments$457.0MUp from $240.3M at fiscal year-end
Long-term debt$5.517BUp from $5.496B at fiscal year-end

The Bigger Story

Microchip’s recovery has broadened beyond a simple rebound from a weak prior-year comparison. Industrial revenue rose 50.3% year over year, data center revenue rose 55.7%, and aerospace and defense increased 41%. Automotive growth was slower but still solid at 19.3%, while compute declined 1.6%.

The company is also seeing a more supply-constrained environment. Management said lead times have extended broadly from historical levels of four to eight weeks to a range of six to 32 weeks across product lines. Book-to-bill remained well above one, backlog increased entering the December quarter, and expedited-shipment requests have risen.

That combination ordinarily supports stronger near-term revenue and utilization. However, Microchip cannot fulfill some demand within the current quarter because of constraints at foundries, outsourced assembly and test providers, and parts of its own manufacturing network. The result is a mixed setup: demand and backlog are improving, but revenue conversion and gross-margin expansion are being limited by manufacturing bottlenecks.

Revenue and Operating Performance

September-quarter revenue exceeded the company’s prior midpoint outlook of $1.604B. The quarter included approximately $53M of infrequent revenue items that are not expected to recur in the December quarter:

  • About $21M from the effect of a pricing change on inventory held in distribution channels.
  • About $22M of licensing revenue above the level expected in the December quarter.
  • About $10M from a long-term customer contract.

All three items carried 100% gross margin, making them important not only for reported revenue but also for the quarter’s 66.5% non-GAAP gross margin.

Excluding licensing revenue, industrial represented 34.6% of sales, followed by data center at 16.7%, aerospace and defense at 16.1%, automotive at 14.2%, communications at 8.2%, consumer appliances at 7.3%, and compute at 2.9%.

Data center revenue exceeded $250M in the September quarter, and management said the business was on track to reach $1B in calendar 2026. Roughly half comes from standard products, such as power controllers, system-management components, Ethernet switches, USB hubs, timing and security products. The other half comes from the Data Center Solutions business unit.

Microchip’s PCIe Gen6 switches and retimers remain an important longer-term opportunity. The company had 19 design wins at the end of September, up from 12 at the end of June, and said the total had reached 24 by the earnings call. Management expects shipments to increase from here, with the design wins ramping at different points during the next year and most in production by the start of calendar 2028. The company did not quantify the revenue potential from those programs.

The company also completed the acquisition of Hailo, an edge AI processor provider, in September and Vorago Technologies, a supplier of radiation-hardened microcontrollers and microprocessors, in October. Management expects Hailo to contribute about $4M and Vorago about $6M of December-quarter revenue.

Profitability and Margins

Microchip’s operating leverage was evident in the quarter. Revenue rose 42.2% year over year, while non-GAAP operating expenses increased more slowly, falling to 27.0% of sales from 32.4% a year earlier. That lifted non-GAAP operating margin to 39.5%, compared with 24.3% in the prior-year quarter.

GAAP operating margin rose to 28.6% from 7.8%. GAAP operating expenses included $90.2M of acquired-intangible amortization, $62.2M of share-based compensation, $7.9M of special charges primarily related to the closure of Fab 2, and $5.3M of other adjustments.

GAAP EPS of $0.68 included a $0.13-per-share tax benefit related to the release of a valuation allowance on tax attributes. Non-GAAP EPS of $0.97 excluded acquisition-related amortization, share-based compensation, restructuring and other charges, as well as preferred-stock dividends and certain tax adjustments.

The margin outlook is less favorable sequentially. Management expects non-GAAP gross margin of 64.0% to 65.0% in the December quarter, down from 66.5% in September. The expected decline reflects the absence of the September quarter’s 100%-margin infrequent revenue, lower production utilization, and the inability to ship certain high-margin products because of supply constraints.

Management also cited planned price increases from foundry and outsourced assembly and test suppliers beginning in January. It does not currently plan another immediate customer price increase, suggesting cost inflation could constrain gross-margin recovery even as product availability improves. The company maintained its long-term non-GAAP model of 65% gross margin, 25% operating expenses, and 40% operating margin.

Demand, Customers and Pricing

Bookings remained strong throughout the September quarter and continued to build in October, according to management. Backlog entering the December quarter was higher than it was entering September, and management said the March-quarter backlog is stronger than the December-quarter backlog was at the same point in the prior cycle.

The key constraint is capacity rather than lack of orders. Microchip said certain high-margin orders cannot be fulfilled in the December quarter and are being scheduled into later periods. The bottleneck extends beyond wafer fabrication: internally produced wafers often still require outsourced assembly and test, where AI-related demand has displaced some capacity used by Microchip.

Management expects incremental capacity to become available over the March and June quarters through additional supplier allocations, qualification of alternative outsourced assembly and test providers, and selective internal capacity additions. These changes require time, and some programs will not reach production until later in the fiscal year.

Customer inventory behavior remains relatively restrained. Management said it has not seen broad-based customer efforts to build excess inventory despite longer lead times. Distributor inventory was 25 days at the end of September, flat sequentially and at the low end of Microchip’s historical range.

What is Microchip’s guidance for Q3 FY2027?

For the quarter ending December 31, 2026, Microchip guided for:

MetricGuidance
Net sales$1.573B to $1.638B
Sequential revenue growthDown 3% to up 1%
GAAP gross margin62.9% to 63.9%
Non-GAAP gross margin64.0% to 65.0%
GAAP operating margin25.5% to 27.2%
Non-GAAP operating margin37.0% to 38.5%
GAAP diluted EPS$0.47 to $0.50
Non-GAAP diluted EPS$0.87 to $0.95
Quarterly capital expendituresAbout $35M

At the midpoint, revenue guidance implies a 1% sequential decline and approximately 35.4% year-over-year growth. Management said a December-quarter decline of 3% to 5% is normal seasonality, and that the midpoint outlook would be 5% to 7% better than normal seasonal trends after accounting for the $53M of September infrequent revenue.

For fiscal 2027, Microchip expects capital expenditures of about $100M. The company has paused most factory expansion projects after reducing investment plans during the prior downturn, but is selectively adding equipment to expand capacity and support research and development.

Balance Sheet, Cash Flow and Capital

Free cash flow improved sharply to $396.1M in the September quarter, compared with $51.6M a year earlier. Cash flow from operations was $419.2M, while capital expenditures were $23.1M.

Cash and short-term investments rose to $457.0M from $240.3M at the end of fiscal 2026. Inventory increased to $1.117B from $1.035B, or 184 days of inventory, up nine days sequentially. Management said the increase reflected receipt of high-value wafers in anticipation of growth and additional finished-goods inventory. Twelve days of inventory consisted of long-life-cycle, high-margin products whose production capacity has been end-of-lifed by supply-chain partners.

Long-term debt was largely unchanged at $5.517B. Management said net debt declined by $31.7M during the quarter after funding the Hailo acquisition, and reported net debt-to-adjusted EBITDA of 2.36 times at quarter-end. The company expects leverage to decline further during fiscal 2027, but indicated that debt reduction remains the priority before reconsidering larger shareholder returns.

Microchip returned about $247.6M to common shareholders through dividends during the September quarter and declared a December-quarter common dividend of $0.455 per share.

What Investors Should Watch

1. Supply Constraints and Revenue Conversion

Backlog, bookings, and extended lead times indicate improving demand, but Microchip must convert that demand into shipments. Progress in outsourced assembly and test capacity, alternative supplier qualifications, and internal production will determine whether delayed high-margin revenue moves into the March and June quarters.

2. Gross Margin Recovery

The December outlook points to a step down from September’s 66.5% non-GAAP gross margin. Investors should watch whether product mix, stronger utilization, and improved supply availability can return margins toward the company’s 65% long-term target despite higher foundry and outsourced manufacturing costs.

3. Data Center Design-Win Ramps

The 24 PCIe Gen6 switch and retimer design wins provide a potentially important future growth driver, but they are not yet a major revenue contributor. Shipment growth over the next year and the timing of customer production ramps will determine how quickly this opportunity affects results.

4. Industrial and Automotive Durability

Industrial was the largest end market and grew 50.3% year over year, while automotive rose 19.3%. Sustained growth in these more diversified markets would reduce the company’s reliance on an uncertain data-center infrastructure cycle.

5. Leverage and Capital Allocation

Free cash flow and net-debt reduction are improving, but long-term debt remains above $5.5B. Management’s willingness to maintain the dividend rather than accelerate repurchases or increases underscores that balance-sheet repair remains a central capital-allocation priority.

AlgovestIQ Takeaway

Microchip’s September quarter confirmed that the company’s cyclical recovery has gained momentum. Revenue beat expectations, profitability recovered sharply, and growth was broad across key industrial, aerospace and defense, automotive, and data-center markets. The company also generated nearly $400M of quarterly free cash flow while continuing to reduce leverage.

However, the headline strength included $53M of infrequent, 100%-margin revenue. That contribution will not repeat in the December quarter, making the sequential comparison less favorable than the core demand picture alone would suggest. The December gross-margin outlook also shows that supply constraints and cost inflation are offsetting some of the benefits from higher bookings and pricing actions.

The central investment question is whether Microchip can translate its higher backlog, extended lead times, and data-center design wins into sustained revenue growth without sacrificing profitability. Management expects more supply availability over the next two quarters, but the timing depends on foundry allocations, outsourced assembly and test capacity, and internal manufacturing execution.

Evidence of rising utilization, shipment conversion of constrained high-margin products, and gross margins holding around the 65% model would strengthen the recovery thesis. Conversely, persistent supply bottlenecks, higher input costs that cannot be passed through, or a sharper slowdown in data-center infrastructure spending would make the current demand signal less valuable to earnings.

How did MCHP stock react?

MCHP closed at $58.35 on Nov 6, 2026, down 10.0% from $64.85 on Nov 5, 2026, the last close before the results were released.

SessionCloseChange
Nov 5, 2026 (before release)$64.85—
Nov 6, 2026$58.35-10.0%

Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.

More from this earnings season

References

  1. Management commentary, analyst questions and outlook discussed on the call. Source: Microchip Technology Incorporated Q2 FY2027 earnings call transcript, as of Nov 5, 2026.
  2. Reported results, segment figures and guidance from the company's results announcement. Source: Microchip Technology Incorporated Form 8-K, Item 2.02 (SEC EDGAR), as of Nov 5, 2026.
  3. Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Nov 5, 2026.

AI-generated analysis based on company-reported earnings data and earnings-call materials. Not investment advice.